M&A Deal Summary

Miraca Holdings Acquires Caris Life Sciences - Anatomic Pathology Business

On November 22, 2011, Miraca Holdings acquired life science company Caris Life Sciences - Anatomic Pathology Business from Caris Diagnostics for 725M USD

Acquisition Highlights
  • This is Miraca Holdings’ 1st transaction in the Life Science sector.
  • This is Miraca Holdings’ largest (disclosed) transaction.
  • This is Miraca Holdings’ 1st transaction in the United States.

M&A Deal Summary

Date 2011-11-22
Target Caris Life Sciences - Anatomic Pathology Business
Sector Life Science
Buyer(s) Miraca Holdings
Sellers(s) Caris Diagnostics
Deal Type Divestiture
Deal Value 725M USD

Search 201,771 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Miraca Holdings

Tokyo, Japan

Category Company
Founded 1950
Sector Life Science
DESCRIPTION

Miraca Holdings, Inc. is engaged in the business consisting of three segments: (i) development, manufacture, and commercialization of in vitro diagnostics, (ii) clinical laboratory testing, and (iii) other healthcare related businesses.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-22 Inform Diagnostics

Irving, Texas, United States

Inform Diagnostics is a provider of anatomic pathology services primarily in the fields of gastroenterology, dermatology, hematology, breast health, and urology. The company's team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Inform Diagnostics continuously improves diagnostic accuracy through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities, and close relationships with clinical partners. Inform Diagnostics was formed in 1996 and is based in Irving, Texas.

Sell -

Seller(S) 1

SELLER

Caris Diagnostics

United States

Category Company
Sector Life Science
DESCRIPTION

Caris Diagnostics, Inc. is a pathology company specializing in gastrointestinal pathology, dermatopathology, hematopathology and urologic pathology services.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 1